Is There a Cardiovascular Rationale for
Is There a Cardiovascular Rationale for the Use of Combined Vasopressin V1a/V2 Receptor Antagonists?
โ
Steven R. Goldsmith
๐
Article
๐
2006
๐
Elsevier Science
๐
English
โ 86 KB